Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections

NCT01077245 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Clostridium Difficile Infection

Interventions

DRUG: MIYA-BM Fine Granules (CBM588)
DRUG: Placebo Fine Granules (without CBM588)

Sponsor

Osel, Inc.